Membranous glomerulonephritis laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 14: Line 14:
* [[Urinalysis]] with examination of the sediment
* [[Urinalysis]] with examination of the sediment
* 24-hour urine collection for protein quantification and [[creatinine clearance]]
* 24-hour urine collection for protein quantification and [[creatinine clearance]]
* [[ANA]] and, if positive, anti-double-stranded DNA (anti-dsDNA), anti-Sm, anti-Ro/SSA, and anti-La/SSB antibodies to rule out any autoimmune disease like SLE
* [[ANA]] and, if positive, anti-double-stranded DNA (anti-dsDNA), anti-Sm, anti-Ro/SSA, and anti-La/SSB antibodies to rule out autoimmune disease ([[SLE]])
* Tests for [[hepatitis B]] and C [[viruses]] and the human immunodeficiency virus ([[HIV]])
* Tests for [[hepatitis B]] and C [[viruses]] and the human immunodeficiency virus ([[HIV]])
* Serum [[C3]] and [[C4]] [[complement]] levels
* Serum [[C3]] and [[C4]] [[complement]] levels

Revision as of 17:30, 19 July 2018

Membranous glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Membranous glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

Ultrasound

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Membranous glomerulonephritis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Membranous glomerulonephritis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Membranous glomerulonephritis laboratory findings

CDC on Membranous glomerulonephritis laboratory findings

Membranous glomerulonephritis laboratory findings in the news

Blogs on Membranous glomerulonephritis laboratory findings

Directions to Hospitals Treating Membranous glomerulonephritis

Risk calculators and risk factors for Membranous glomerulonephritis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]

Overview

Laboratory Findings

  • The laboratory workup of membranous glomerulonephritis includes blood, urine and anti-bodies workup[1][2]
  • Comprehensive chemistry panel including serum albumin
  • Complete blood count
  • Urinalysis with examination of the sediment
  • 24-hour urine collection for protein quantification and creatinine clearance
  • ANA and, if positive, anti-double-stranded DNA (anti-dsDNA), anti-Sm, anti-Ro/SSA, and anti-La/SSB antibodies to rule out autoimmune disease (SLE)
  • Tests for hepatitis B and C viruses and the human immunodeficiency virus (HIV)
  • Serum C3 and C4 complement levels
  • Serum free light chains (SFLCs) and serum protein electrophoresis (SPEP) with immunofixation
  • Anti-PLA2R antibody (by enzyme-linked immunosorbent assay) ELISA

References

  1. Qin W, Beck LH, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z (June 2011). "Anti-phospholipase A2 receptor antibody in membranous nephropathy". J. Am. Soc. Nephrol. 22 (6): 1137–43. doi:10.1681/ASN.2010090967. PMC 3103733. PMID 21566055.
  2. Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R, Mathieson PW, Ronco P, Brenchley PE, Wetzels JF (October 2012). "Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy". J. Am. Soc. Nephrol. 23 (10): 1735–43. doi:10.1681/ASN.2012030242. PMC 3458465. PMID 22956816.

Template:WH Template:WS